Hydrochlorothiazide losartan side effects
Pro Research Analysisby
Searched over 200M research papers
Consensus Meter
Side Effects of Hydrochlorothiazide and Losartan Combination Therapy
Introduction to Hydrochlorothiazide and Losartan
Hydrochlorothiazide (HCTZ) and losartan are commonly prescribed together to manage hypertension. This combination leverages the diuretic effect of HCTZ and the angiotensin II receptor blocking action of losartan to effectively lower blood pressure. However, like all medications, this combination can have side effects.
Common Side Effects of Losartan and Hydrochlorothiazide
General Adverse Experiences
In clinical trials, the most frequently reported side effects for patients treated with losartan included headache, dizziness, upper respiratory infections, and fatigue. These side effects were also common in patients treated with HCTZ . Specifically, dizziness was noted as a drug-related side effect more often in losartan-treated patients compared to those on placebo.
Specific Side Effects of the Combination Therapy
When losartan is combined with HCTZ, the side effects can vary slightly. In a study comparing losartan/HCTZ with enalapril/HCTZ, it was found that the combination of losartan and HCTZ was associated with fewer undesirable symptoms, particularly a lower incidence of cough compared to enalapril/HCTZ. Additionally, losartan/HCTZ did not increase serum uric acid levels, unlike enalapril/HCTZ.
Comparative Safety and Tolerability
Losartan vs. Other Antihypertensive Agents
Losartan, when compared to other antihypertensive agents such as atenolol, felodipine, and ACE inhibitors, demonstrated a better tolerability profile. The rates of discontinuation due to adverse experiences were lower in patients treated with losartan or losartan plus HCTZ compared to those on placebo. This suggests that the combination therapy is generally well-tolerated.
Losartan/HCTZ vs. Benazepril/HCTZ
In elderly patients, the combination of losartan and HCTZ was found to have fewer drug-related adverse reactions compared to benazepril and HCTZ. This indicates a better safety profile for the losartan combination in this demographic.
Impact on Renal Function and Proteinuria
Renal Safety
Studies have shown that the combination of losartan and HCTZ can have beneficial effects on renal function. For instance, in hypertensive patients inadequately controlled with losartan alone, adding HCTZ improved renal parameters such as urine albumin creatinine ratio (ACR) and renal resistive index (RRI) . However, indapamide combined with losartan was found to be more effective than HCTZ in improving renal tubular injury and reducing vascular stiffness .
Proteinuria Reduction
The combination of losartan and HCTZ has also been shown to significantly reduce proteinuria, especially when combined with a low-sodium diet. This combination was particularly effective in patients who did not respond to losartan monotherapy.
Conclusion
The combination of hydrochlorothiazide and losartan is effective in managing hypertension and generally well-tolerated. Common side effects include headache, dizziness, and upper respiratory infections, with a lower incidence of cough compared to other combinations like enalapril/HCTZ. The combination also shows a favorable safety profile in elderly patients and has beneficial effects on renal function and proteinuria. Overall, losartan and HCTZ provide a robust therapeutic option for patients with hypertension, particularly those who experience side effects with other antihypertensive therapies.
Sources and full results
Most relevant research papers on this topic